U.S. overdose deaths involving psychostimulants other than cocaine, largely methamphetamine, increased 180% among adults under age 65 between 2015 and 2019, to 15,489, according to a study by the National Institute on Drug Abuse published this week in JAMA Psychiatry. The number of people reporting methamphetamine use increased 43% over the period, suggesting that increases in methamphetamine use disorder, frequent use and use of other drugs at the same time may be contributing to the rise in deaths, the authors said.

“What makes these data even more devastating is that currently, there are no approved medications to treat methamphetamine use disorder,” said Emily Einstein, chief of NIDA’s Science Policy Branch and a co-author of the study. 
 

Related News Articles

Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
The AHA released a new toolkit to improve continuity of care for patients with opioid and stimulant use disorders. Developed with support from the Centers for…
Headline
The Substance Abuse and Mental Health Services Administration July 28 released its latest national survey on drug use and mental health. Among the findings,…
Headline
The U.S. Department of Health and Human Services July 10 rescinded a policy that extended certain federal public benefits to immigrants lacking permanent legal…
Headline
The House June 4 passed the AHA-supported SUPPORT Act (H.R. 2483) by a 366-57 vote. The legislation reauthorizes key prevention, treatment and recovery…
Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…